T1050 Dyspeptic Symptoms and Sleep Disturbance: A Report from a Large Observational Study in Low-Dose Acetylsalicylic Acid Users

2009 ◽  
Vol 136 (5) ◽  
pp. A-488
Author(s):  
Christopher Chappel ◽  
David Neuman ◽  
Vincent J. Thompson ◽  
Stephen Pratt ◽  
John P. Delgado ◽  
...  
2010 ◽  
Vol 21 (5) ◽  
pp. 949-954 ◽  
Author(s):  
A. Guerrieri-Gonzaga ◽  
E. Botteri ◽  
M. Lazzeroni ◽  
N. Rotmensz ◽  
A. Goldhirsch ◽  
...  

2010 ◽  
Vol 55 (10) ◽  
pp. A56.E536
Author(s):  
James Scheiman ◽  
Johan Herlitz ◽  
Philip Devereaux ◽  
Emma Naucler ◽  
Lars-Erik Svedberg

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1345-P
Author(s):  
JING WANG ◽  
LEISHEN WANG ◽  
SHUANG ZHANG ◽  
HUIKUN LIU ◽  
JUNHONG LENG ◽  
...  

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1433-P
Author(s):  
YUN SHEN ◽  
PENG WANG ◽  
LEISHEN WANG ◽  
SHUANG ZHANG ◽  
HUIKUN LIU ◽  
...  

2021 ◽  
Vol 6 (4) ◽  
pp. S140
Author(s):  
W. Hu ◽  
C. Duqun ◽  
C. Yinghua ◽  
G. Erzhi ◽  
L. Lixuan ◽  
...  

2018 ◽  
Vol 3 (4) ◽  
pp. 199-206
Author(s):  
Nelly Lonca ◽  
Fabienne Maillard ◽  
Géraldine Leguelinel ◽  
Tahmer Sharkawi ◽  
Ian Soulairol

Abstract Background The intolerance to Acetylsalicylic Acid (ASA) can be detected by conducting oral provocation testing (OPT), which is to gradually introduce low doses of ASA. To perform this test, hospital pharmacies compound small batches of different low-dosage ASA capsules. This work aims to validate a method for fast HPLC-UV assay that allows routine quality control and physicochemical stability studies of capsules. Methods The chromatographic separation is performed using a C18 column Kinetex (100 A, 50×4.6 mm, 2.6 µm) equipped with a precolumn C18. Separation is achieved using a mobile phase composed of water-acetonitrile-orthophosphoric acid (68:32:0.2 v/v/v) at a flow rate of 0.8 mL/min and UV detection at 237 nm. Results Validation shows that the method was suitable for routine analysis and could be used to perform stability studies. Conclusions The 5, 25, 100 and 250 mg dosed capsules show acceptable stability over 12 months, while the 1 mg dosed capsule show an unacceptable degradation of more than 15 % after 3 months. Therefore, hospital pharmacy can plan the manufacture of capsules and anticipate the requests of doctors.


Sign in / Sign up

Export Citation Format

Share Document